AFG3L2 and Ataxia: It upregulates glutamate receptor EAAT2 in the astrocytic glial cells and ameliorates ataxia in heterozygous mutated AFG3L2 by inhibiting glutamate excitotoxicity and creating healthy Purkinje cell and glial connections [53].